-transparent.png){kind=logo}
The aim of this prospective study was to evaluate the efficacy of propafenone in suppressing various arrhythmias in a group of children who were patients in the Pediatric Cardiology Unit of Hacettepe University Children's Hospital. Seven of the 13 children (53.8%) with ventricular ectopics, all three children with paroxysmal re-entry atrioventricular tachycardia, and two of the three children with paroxysmal atrial tachycardia were treated successfully with propafenone. The drug did not cause any side effects or arrhythmogenesis. The median dosage of propafenone at discharge was 300 mg/m2/day (range 250-400 mg/m2/day) every eight hours. Our findings confirm the efficacy and safety of propafenone for the treatment of childhood arrhythmias.
A Celiker, and
S Ozer, and
S Ozme, and
S Ozkutlu, and
O Kahramanyol
August 1994,
European heart journal,
A Celiker, and
S Ozer, and
S Ozme, and
S Ozkutlu, and
O Kahramanyol
January 2012,
Kardiologiia,
A Celiker, and
S Ozer, and
S Ozme, and
S Ozkutlu, and
O Kahramanyol
April 1990,
The Medical letter on drugs and therapeutics,
A Celiker, and
S Ozer, and
S Ozme, and
S Ozkutlu, and
O Kahramanyol
February 1992,
The American journal of the medical sciences,
A Celiker, and
S Ozer, and
S Ozme, and
S Ozkutlu, and
O Kahramanyol
December 1988,
European heart journal,
A Celiker, and
S Ozer, and
S Ozme, and
S Ozkutlu, and
O Kahramanyol
March 1985,
Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde,
A Celiker, and
S Ozer, and
S Ozme, and
S Ozkutlu, and
O Kahramanyol
January 1995,
Drug safety,
A Celiker, and
S Ozer, and
S Ozme, and
S Ozkutlu, and
O Kahramanyol
September 1984,
Canadian Medical Association journal,
A Celiker, and
S Ozer, and
S Ozme, and
S Ozkutlu, and
O Kahramanyol
November 1984,
The American journal of cardiology,
A Celiker, and
S Ozer, and
S Ozme, and
S Ozkutlu, and
O Kahramanyol
August 1993,
The American journal of cardiology,
